Trial
NCT00560118
Fotemustine in Treating Patients With Metastatic Melanoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Collaborators
—
Condition
Melanoma (Skin)
Intervention
fotemustine
Why stopped
In view of the slowness of the inclusions and the difficulty of carrying out the study, it was decided to put an end to this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-14